Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Non-Current Assets (2016 - 2025)

Lipocine (LPCN) has disclosed Other Non-Current Assets for 13 consecutive years, with $23753.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $23753.0, compared with a TTM value of $23753.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $23753.0, changed 0.0% over the prior year.
  • Other Non-Current Assets was $23753.0 for Q3 2025 at Lipocine, roughly flat from $23753.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $23753.0 in Q1 2021 and bottomed at $23753.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $23753.0, with a median of $23753.0 recorded in 2021.
  • The sharpest move saw Other Non-Current Assets plummeted 99.52% in 2021, then changed 0.0% in 2022.
  • Year by year, Other Non-Current Assets stood at $23753.0 in 2021, then changed by 0.0% to $23753.0 in 2022, then changed by 0.0% to $23753.0 in 2023, then changed by 0.0% to $23753.0 in 2024, then changed by 0.0% to $23753.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for LPCN at $23753.0 in Q3 2025, $23753.0 in Q2 2025, and $23753.0 in Q1 2025.